ThermoGenesis Holdings Inc. (NASDAQ: THMO) stock jumped 5.09% on Friday to $0.22 against a previous-day closing price of $0.21. With 2.88 million shares changed hands, the volume of the stock remained heavier than its average volume of 2.61 million shares. During the session, the Medical Devices company that operates in wider Healthcare sector, reached to the highest price of $0.2450 whereas the lowest price it dropped to was $0.2030. The 52-week range on THMO shows that it touched its highest point at $2.50 and its lowest point at $0.09 during that stretch. Beta for the stock currently stands at 2.81.
Do You Know The Best Place To Find Gains In Volatile Markets?
In today's chaotic marketplace, the biggest gains will come from some currently-small companies that pass by older, larger businesses still stuck in a pre-pandemic world. The trick is figuring out which small caps will be tomorrow's winners. That's why StockWire News has put together a special Wealth Building Report, highlighting 3 small cap stocks set to soar in 2023.
Click here for full details and to join for free.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of THMO was down-trending over the past week, with a drop of -16.48%, but this was down by -17.52% over a month. Three-month performance dropped to -49.99% while six-month performance fell -74.53%. The stock lost -90.47% in the past year, while it has lost -77.72% so far this year.
Float and Shares Shorts:
At present, 12.29 million THMO shares are outstanding with a float of 7.80 million shares on hand for trading. On Jul 14, 2022, short shares totaled 0.79 million, which was 2.51% higher than short shares on Jun 14, 2022. In addition to Dr. Xiaochun Xu M.B.A., Ph.D. as the firm’s Chairman & CEO, Mr. Jeffery Cauble CPA serves as its CFO, Principal Financial & Accounting Officer and Corp. Sec.
Through their ownership of 0.89% of THMO’s outstanding shares, institutional investors have minority control over the company. Other institutions hold 5.52% of THMO, in contrast to 0.48% held by mutual funds. Shares owned by individuals account for 0.41%. As the largest shareholder in THMO with 0.25% of the stake, The Vanguard Group, Inc. holds 77,065 shares worth 77,065. A second-largest stockholder of THMO, BlackRock Fund Advisors, holds 67,135 shares, controlling over 0.21% of the firm’s shares. Geode Capital Management LLC is the third largest shareholder in THMO, holding 43,374 shares or 0.14% stake. With a 0.25% stake in THMO, the Vanguard Extended Market Index Fu is the largest stakeholder. A total of 77,065 shares are owned by the mutual fund manager. The Fidelity Extended Market Index Fu, which owns about 0.10% of THMO stock, is the second-largest Mutual Fund holder. It holds 31,919 shares valued at 8810.0. Vanguard Invt. Fds. ICVC – US Equ holds 0.02% of the stake in THMO, owning 7,231 shares worth 1996.0.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on Mar 30, 2022, THMO reported revenue of $2.66M and operating income of -$1.21M. Over the past year, revenue came in at $10.44M while operating income stood at -$6.78M. It generated -$1.91M net income for the quarter, which came to -$10.88M over the last twelve months. The EBITDA in the recently reported quarter was -$1.06M and diluted EPS was -$0.16. EBITDA for the full year was -$5.36M.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for THMO since 1 analysts follow the stock currently. There are 1 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With THMO analysts setting a high price target of $6.00 and a low target of $6.00, the average target price over the next 12 months is $6.00. Based on these targets, THMO could surge 2627.27% to reach the target high and rise by 2627.27% to reach the target low. Reaching the average price target will result in a growth of 2627.27% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. THMO will report FY 2021 earnings on 03/27/2023. Analysts have provided yearly estimates in a range of -$0.80 being high and -$0.80 being low. For THMO, this leads to a yearly average estimate of -$0.80. The earnings surprise of a firm occurs when the actual results change from the consensus earnings estimate. ThermoGenesis Holdings Inc. reported -$0.16 EPS. The surprise factor in the prior quarter was -$0.16. Based on analyst estimates, the high estimate for the next quarter is -$0.06 and the low estimate is -$0.06. The average estimate for the next quarter is thus -$0.06.
Summary of Insider Activity:
Insiders traded THMO stock several times over the past three months with 1 Buys and 0 Sells. In these transactions, 10,552,234 shares were bought while 0 shares were sold. The number of buy transactions has increased to 1 while that of sell transactions has remained unmoved to 0 over the past year. The total number of shares bought during that period was 10,552,234 while 0 shares were sold.